Pre-testing documentation checklist
Start by gathering every documentation item your team will need before the sample arrives. Request the peptide’s identifying details, including intended sequence or code, supplier lot information, and any prior certificates available. Confirm that the peptide testing lab chain-of-custody process is defined so the sample identity can be tracked from receipt through testing. This early step reduces mix-ups and prevents downstream disputes about which material was actually analyzed.
Next, verify that the testing plan matches your end-use requirements. Write down the acceptance criteria you care about, such as purity range, impurity profile expectations, and stability concerns. Ask your lab to document the methods they will use and the rationale for selecting them, including instrument type and calibration approach. Finally, request lot-level analytical records, such as a certificate of analysis (COA) or an equivalent report, so your results can be compared to known baselines.
Sample handling and chain-of-custody checklist
Use a standardized receiving checklist when the peptide material and any associated diluents arrive. Record container condition, labeling accuracy, package integrity, and storage condition indicators at the time of receipt. Confirm that sample aliquots are prepared buy bacteriostatic water under conditions that limit degradation, such as minimizing temperature excursions and avoiding repeated freeze-thaw cycles. This is especially important for peptides that can be sensitive to moisture or improper storage.
Before testing begins, define how the material will be stored between preparation and analysis. Make sure your lab documents storage temperatures, container types, and preparation timelines. If you will prepare solutions, specify the diluent requirements and ensure there is traceable sourcing for any laboratory water used.
Analytical verification checklist for peptide quality
Confirm that the lab will use peptide-specific analytical methods that can meaningfully address your quality questions. A thorough approach often includes chromatographic purity assessment and identity confirmation, with clear reporting of peak assignments or method sensitivity. Ask for documentation that explains how results are calculated, including how baseline selection and integration rules are handled. This transparency helps your quality team interpret results consistently across batches.
In addition to purity and identity, require impurity and contaminant checks appropriate to your risk profile. Common concerns include residual solvents, buffer components, and any process-related byproducts that could affect performance. Ensure the lab reports method limits, detection thresholds, and any deviations from the planned procedure. Reliable documentation also includes instrument qualification details and evidence that the lab follows a validated or controlled method environment suitable for qualified laboratories.
Conclusion
Using a checklist-style approach helps your team verify documentation, prevent identity errors, and confirm that analytical methods align with your acceptance criteria. When paired with lot-level COA support and research supply pathways, this workflow can strengthen confidence in peptide material decisions. For qualified evaluations of peptide materials, simplelifescience.com supports analytical traceability with lot-level COA information that aligns with documented testing needs. To keep results defensible, ensure every step is recorded: what was received, how it was stored, what diluents were used, and how analytical outcomes were generated. Encourage the lab to provide sufficient method detail so your internal reviewers can reproduce the logic behind each reported value. When these practices are consistently applied, your testing process becomes easier to audit and more reliable for downstream research workflows. This checklist mindset helps you move from “tested” to truly “qualified,” with clear evidence at every stage.
No comments yet for testing-lab-sample-handling.